Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)
CNY 18.83
(1.4%)
CNY 18.83
(1.4%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.48 Billion CNY | 17.06% |
| 2022 | 2.12 Billion CNY | 26.71% |
| 2021 | 1.67 Billion CNY | 9.01% |
| 2020 | 1.53 Billion CNY | 72.62% |
| 2019 | 889.81 Million CNY | 15.41% |
| 2018 | 771 Million CNY | 25.81% |
| 2017 | 612.85 Million CNY | 11.87% |
| 2016 | 547.8 Million CNY | 0.0% |
| 2014 | 475.64 Million CNY | 6.59% |
| 2013 | 446.22 Million CNY | 24.42% |
| 2012 | 358.63 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.49 Billion CNY | 0.43% |
| 2024 Q2 | 2.48 Billion CNY | -0.42% |
| 2024 Q3 | 2.55 Billion CNY | 2.86% |
| 2023 Q3 | 2.21 Billion CNY | 13.16% |
| 2023 Q4 | 2.48 Billion CNY | 12.02% |
| 2023 FY | 2.48 Billion CNY | 17.06% |
| 2023 Q1 | 2.3 Billion CNY | 8.68% |
| 2023 Q2 | 1.95 Billion CNY | -15.03% |
| 2022 Q4 | 2.12 Billion CNY | -0.17% |
| 2022 FY | 2.12 Billion CNY | 26.71% |
| 2022 Q3 | 2.12 Billion CNY | 8.31% |
| 2022 Q2 | 1.96 Billion CNY | 3.28% |
| 2022 Q1 | 1.89 Billion CNY | 13.47% |
| 2021 Q2 | 1.61 Billion CNY | -2.75% |
| 2021 Q3 | 1.77 Billion CNY | 9.69% |
| 2021 Q1 | 1.65 Billion CNY | 8.04% |
| 2021 FY | 1.67 Billion CNY | 9.01% |
| 2021 Q4 | 1.67 Billion CNY | -5.41% |
| 2020 Q3 | 1.07 Billion CNY | 14.41% |
| 2020 FY | 1.53 Billion CNY | 72.62% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q4 | 1.53 Billion CNY | 42.25% |
| 2020 Q2 | 943.84 Million CNY | 0.0% |
| 2019 Q2 | 901.12 Million CNY | 0.0% |
| 2019 FY | 889.81 Million CNY | 15.41% |
| 2019 Q4 | 889.81 Million CNY | 0.0% |
| 2019 Q3 | 889.81 Million CNY | -1.25% |
| 2019 Q1 | 901.12 Million CNY | 0.0% |
| 2018 FY | 771 Million CNY | 25.81% |
| 2017 FY | 612.85 Million CNY | 11.87% |
| 2016 FY | 547.8 Million CNY | 0.0% |
| 2014 FY | 475.64 Million CNY | 6.59% |
| 2013 FY | 446.22 Million CNY | 24.42% |
| 2012 FY | 358.63 Million CNY | 0.0% |